Skip to main content
Watch Insiders
ANIKHealthcare

Anika Therapeutics Inc. (ANIK) Insider Trading

In the last 90 days, 1 Anika Therapeutics Inc. (ANIK) insider reported 1 open-market purchase totaling $41,060 and no sales. The most recent open-market purchase was reported on Aug 4, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$41,060
Corporate buyers
1
Latest transaction
Aug 4, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 4, 2026Gary P FischettiDirectorOpen Market Purchase2,000$20.53$41,060
May 1, 2026John B Henneman IIIDirectorOpen Market Purchase5,000$14.66$73,320
Apr 30, 2026Stephen D. GriffinPresident and CEOOpen Market Purchase12,200$12.29$149,881

Common questions

ANIK insider trading FAQ

Are ANIK insiders buying or selling?
Over the last 90 days, ANIK insiders were net buyers, reporting $41,060 of open-market purchases and $0.00 of sales.
When was the last ANIK insider purchase?
The most recent open-market purchase of Anika Therapeutics Inc. stock by an insider was reported on Aug 4, 2026, one of 1 purchase in the last 90 days.
Where does ANIK insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Anika Therapeutics Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.